ReviewCell death discovery2026
Liquid-liquid phase separation-driven regulated cell death: from molecular mechanisms to therapeutic strategies.
Review in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Functional amyloids as molecular switches: emerging roles in diverse signalling pathways.Biochemical Society transactions · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Regulated cell death (RCD) is a tightly controlled biological process essential for development, tissue homeostasis, and host defense. Despite extensive investigation, how these signaling pathways are spatially and temporally organized to ensure precise cell death decisions remains incompletely understood. Liquid-liquid phase separation (LLPS), a biophysical mechanism driving the formation of dynamic biomolecular condensates, has emerged as a fundamental principle for cellular organization, signal integration, and stress adaptation. Increasing evidence indicates that LLPS plays a critical role in orchestrating cell fate decisions; however, its involvement in RCD has not yet been systematically defined. In this review, we provide a comprehensive overview of LLPS in the context of RCD. We summarize the physicochemical principles, molecular determinants, and regulatory factors governing LLPS, as well as the functional properties of phase-separated condensates, and then discuss how LLPS modulates key RCD pathways, including apoptosis, necroptosis, autophagy-dependent cell death, pyroptosis, and ferroptosis, highlighting shared and pathway-specific regulatory mechanisms. Furthermore, we examine the pathological consequences of aberrant phase separation-mediated RCD in human diseases and discuss emerging therapeutic strategies aimed at targeting LLPS-driven cell death processes. Finally, we catalog RCD-associated proteins with phase separation potential and outline major conceptual and technical challenges, proposing future directions for this rapidly evolving field.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.